» Authors » Andrew Gilman

Andrew Gilman

Explore the profile of Andrew Gilman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 388
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gu P, Clifford E, Gilman A, Chang C, Moss E, Fudman D, et al.
Pathophysiology . 2022 Jul; 29(3):383-393. PMID: 35893600
Low socioeconomic status (SES) is associated with greater morbidity and increased healthcare resource utilization (HRU) in IBD. We examined whether a financial assistance program (FAP) to improve healthcare access affected...
2.
Gu P, Chhabra A, Chittajallu P, Chang C, Mendez D, Gilman A, et al.
Inflamm Bowel Dis . 2021 Jul; 28(5):657-666. PMID: 34291800
Background: Data describing the effect of obesity on antitumor necrosis factor (anti-TNF) treatment response are inconsistent. Visceral adipose tissue (VAT) is a superior marker of adiposity to body mass index....
3.
Krummel E, Gilman A
Int J Circumpolar Health . 2016 Dec; 75:33822. PMID: 27974140
Background: Arctic residents can be exposed to a wide range of contaminants through consumption of traditional (country) foods (i.e. food from wild animals and plants that are hunted, caught or...
4.
King A, Kamani N, Bunin N, Sahdev I, Brochstein J, Hayashi R, et al.
Am J Hematol . 2015 Sep; 90(12):1093-8. PMID: 26348869
Fifty-two children with symptomatic sickle cell disease sickle cell disease (SCD) (N = 43) or transfusion-dependent thalassemia (N = 9) received matched sibling donor marrow (46), marrow and cord product...
5.
Ustun C, Reiter A, Scott B, Nakamura R, Damaj G, Kreil S, et al.
J Clin Oncol . 2014 Aug; 32(29):3264-74. PMID: 25154823
Purpose: Advanced systemic mastocytosis (SM), a fatal hematopoietic malignancy characterized by drug resistance, has no standard therapy. The effectiveness of allogeneic hematopoietic stem-cell transplantation (alloHCT) in SM remains unknown. Patients...
6.
Bao L, Cowan M, Dunham K, Horn B, McGuirk J, Gilman A, et al.
J Immunother . 2012 Mar; 35(3):293-8. PMID: 22421947
Adoptive immunotherapy with cytomegalovirus (CMV)-specific cytotoxic T lymphocytes (CTL) is an effective strategy for preventing and treating viral reactivation after allogeneic stem cell transplantation (SCT). We have shown previously that...
7.
Pavletic S, Martin P, Lee S, Mitchell S, Jacobsohn D, Cowen E, et al.
Biol Blood Marrow Transplant . 2006 Mar; 12(3):252-66. PMID: 16503494
The lack of standardized criteria for quantitative measurement of therapeutic response in clinical trials poses a major obstacle for the development of new agents in chronic graft-versus-host disease (GVHD). This...
8.
Shier L, Schultz K, Imren S, Regan J, Issekutz A, Sadek I, et al.
Biol Blood Marrow Transplant . 2004 Aug; 10(9):624-34. PMID: 15319774
A recent phase III trial comparing granulocyte colony-stimulating factor (G-CSF)-stimulated bone marrow (G-BM) and G-CSF-mobilized peripheral blood (G-PB) in matched sibling allograft recipients showed that G-BM produced a similar hematologic...
9.
Berner J, Gilman A
Int J Hyg Environ Health . 2003 Sep; 206(4-5):351-62. PMID: 12971690
In Western Hemisphere arctic regions, scientific findings in humans, wildlife, and the environment have resulted in major governmental policy formulations. Government policy resulted in establishment of an effective international organization...
10.
Sims S, Barker G, Gilman A
J Clin Pediatr Dent . 2002 Aug; 26(4):401-4. PMID: 12175136
The treatment for pediatric cancer can have serious oral complications that adversely affect prognosis. Dental intervention to pediatric cancer patients is crucial in influencing side effects of therapy. This case...